Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses

Preferable treatments for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with brain metastasis are elusive. The study intended to estimate the relative efficacy and safety of systemic therapies. Clinical trials about therapies for EGFR-mutant, brain-metastatic NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Binghao, Wang, Yuekun, Wang, Yaning, Chen, Wenlin, Zhou, Lizhou, Liu, Peng Hao, Kong, Ziren, Dai, Congxin, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425486/
https://www.ncbi.nlm.nih.gov/pubmed/32669477
http://dx.doi.org/10.18632/aging.103455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425486/
https://www.ncbi.nlm.nih.gov/pubmed/32669477
http://dx.doi.org/10.18632/aging.103455

Ejemplares similares